PTC518 clinical trials

A Phase 2a, Randomized, Placebo-controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects with Huntington’s Disease

This study is testing a new medicine, PTC518, for Huntington's Disease. Researchers want to see if it's safe, how well it works, and what dose might be best. Participants will receive either the medicine or a dummy pill.